Hologic (HOLX) authorizes new stock repurchase program

On September 12, 2024, the Board of Directors of Hologic, Inc. (the “Company”) (NASDAQ: HOLX) authorized a new stock repurchase program, with a five-year term, to repurchase up to $1.5 billion of the Company’s outstanding common stock. This new stock repurchase authorization is in addition to the Company’s prior stock repurchase authorization, which has approximately $190 million remaining as of September 12, 2024.

The timing of any stock repurchases will be based upon the continuing analysis of market, financial, and other factors by the Company’s management. Repurchases under the authorized stock repurchase program may be made using a variety of methods, which may include, but are not limited to, open market purchases, privately negotiated transactions, accelerated share repurchase agreements, or purchases pursuant to a Rule 10b5-1 plan under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The authorized stock repurchase program may be suspended, delayed or discontinued at any time.

You May Also Be Interested In